Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 70518-4265

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70518-4265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)

Chemical structure diagram of cyclobenzaprine hydrochloride, showing the molecular framework and presence of the hydrochloride group (HCl).*

FDA Label Image

Remedy_label (Remedy Label)

Cyclobenzaprine hydrochloride 7.5 mg film-coated tablets packaging label displaying a quantity of 90 tablets. The label includes the product name, strength, dosage form, manufacturer Unichem in Ghaziabad, India, and repackager RemedyRepack Inc. in Indiana, PA. It also shows the NDC 70518-4265-00 and storage instructions between 20-25°C with permitted excursions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.